Merck Pulls Arthritis Drug Off Market
364643
Merck &amp; Co Inc. on Thursday pulled its arthritis drug Vioxx off the market after a study showed it doubled the risk of heart attack and stroke, a move that sent its
710057
The maker of the popular arthritis drug Vioxx is removing it from markets worldwide after a new study found that long-term users face increased risks for heart attack and stroke.
352365
Merck & Co Inc. MRK.N on Thursday  pulled its arthritis drug Vioxx off the market after a study  showed it doubled the risk of heart attack and stroke, a move  that sent its shares plunging and erased $25 billion from its  market value.
346665
Doctors were bombarded with phone calls from worried patients following the announcement last week that drug manufacturer Merck had pulled its popular arthritis drug, Vioxx, from the market because of safety concerns.
57265
Merck &amp; Co.&#39;s decision to pull its Vioxx anti-arthritis drug from the markets due to severe side effects left pharmaceutical sector mixed Thursday.
646131
U.S. drugs giant Merck & Co Inc. should have pulled its Vioxx painkiller from the market four years ago because data showing it raised the risk of heart attacks has existed since 2000, Swiss scientists said on Friday.
108019
Merck announced that it would stop selling Vioxx, because a study found that it doubled patients' risk of heart attack and strokes.
382436
Drug giant Pfizer Inc. reiterated Thursday that its arthritis drug Celebrex was safe to use after competitor Merck &amp; Co. pulled its arthritis drug Vioxx off the market worldwide after studies showed it raised the risk of heart attack.
150871
Merck (MRK) said Thursday that it is withdrawing its arthritis drug Vioxx globally following indications that the drug raises the risk of heart attack and stroke.
437541
Shares of Merck and Co. plunged nearly 27 percent Thursday on news that the pharmaceutical giant was pulling the popular arthritis pain medication Vioxx off the market in the largest drug withdrawal in US history.
496294
The withdrawal of Merck &amp; Co. Inc.&#39;s arthritis drug Vioxx will make it harder for drug companies to win approval for products aimed at big patient populations as regulators
19693
An arthritis drug should have been taken off the market years before it was finally withdrawn, say researchers. Manufacturer Merck withdrew Vioxx in September after evidence linking it to heart problems.
156898
Pharmaceutical giant Merck &amp; Co. chose to go on the offensive and voluntarily withdraw its arthritis drug Vioxx from the market Thursday.
195152
Merck &amp; Co. yesterday pulled the blockbuster pain medicine Vioxx off the market, announcing that a new company-sponsored study showed the drug doubled the risk
241280
Merck &amp; Co. (MRK.N: Quote, Profile, Research) on Thursday withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke.
768203
NEW YORK - Stocks were mixed Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent